MedTrace Logo

The Burden of Lupus in Canada From a Patient Perspective: A Canadian Real-World PROxy Study

NCT07267091 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88

Last updated 2026-01-29

No results posted yet for this study

Summary

This study aims to capture the Canadian patient experience, burden, barriers, and treatment preferences. The findings will generate real-world evidence to support patient-centered care and guide healthcare providers, researchers, and decision-makers in improving support and treatment for people living with lupus.

Conditions

  • Lupus
  • Lupus Arthritis
  • Lupus Arthritis, Systemic Lupus Erythematosus
  • Quality of Life (QOL)

Interventions

OTHER

No Intervention: Observational Cohort

No specific intervention is assess in this study. Observational cohort.

Sponsors & Collaborators

  • PeriPharm

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-11-03
Primary Completion
2026-01-23
Completion
2026-01-23

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07267091 on ClinicalTrials.gov